Searched for
MONTELUKAST TABLETS
Paracetamol to PAN-D: CDSCO finds over 50 sub-standard drugs. Check full list of medicinesThe Central Drugs Standard Control Organisation (CDSCO) has flagged over 50 drugs, including Paracetamol, as 'not of standard quality'. The...- Costs of 127 medicines set to go down post NPPA's 5th price capAmong the 127 medications on the NPPA's list are paracetamol, amoxycillin, rabeprazole, and metformin. Patients frequently make use of many...
- NPPA tells chief secys to keep tabs on API availabilityIn a letter to the chief secretaries, the National Pharmaceutical Pricing Authority (NPPA) has asked them to ensure that there is no violat...
- Unichem Labs gets USFDA nod for asthma drugThe tablets are indicated for prophylaxis and chronic treatment of asthma in adults and pediatric patients - 12 months of age and older.
- Aurobindo Pharma, Cadila recall drugs from US marketPantoprazole Sodium delayed-release tablets are used for treatment of erosive inflammation of the esophagus due to acid reflux.
- Ajanta Pharma launches generic asthma treatment tablets in USAjanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American marke...
- Unichem gets USFDA nod for generic asthma treatment tabletsDrug firm Unichem Laboratories has received approval from the US health regulator for its Montelukast Sodium tablets used in prevention and...
- Ajanta Pharma gets USFDA nod for generic asthma treatment drugDrug firm Ajanta Pharma has received final approvals from the US health regulator for generic montelukast tablets and oral granules.
- Sensex rangebound, Nifty trades around 8950; top ten stocks in focusTracking the momentum, the Nifty is trading around its crucial level of 8950, weighed by losses in autos, banks, FMCG and metal stocks.
- Ten stocks in focus in Tuesday's tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Jubilant Life gets USFDA nod for generic anti-asthma tablets"This includes 72 ANDAs filed in the US, of which 35 have been approved and 46 dossier filings in Europe. So far, we have received 10 ANDA ...
- Pharmaceutical exports slow down due to approval delays and recallsThis is the first time in the recent years that the Indian pharma exports saw single digit growth in dollar terms.
- Glenmark recalls three drugs from US marketGlenmark Generics is recalling multiple lots of three of its drugs from the US market due to "odd smell", according to US FDA.
- Glenmark Generics recalls anti-asthma drug from US marketGlenmark Generics is recalling from the US market multiple lots of Montelukast Sodium tablets (10 mg) on "off-odour" complaints.
- Aurobindo Pharma, Glenmark get FDA nod for generic montelukast sodium tabletsNew Delhi Drug firms Aurobindo Pharma and Glenmark have received approval from the US health regulator to manufacture and market generic mo...
- Aurobindo Pharma, Glenmark get USFDA nod for generic asthma drugAurobindo, Glenmark today said they have received approval from the US health regulator to manufacture, market generic montelukast tablets.
- Indian pharma companies like Aurobindo and Glenmark set to gain from USFDA nod for asthma drugIndian drug makers are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and ...
- Glenmark Pharmaceuticals receives USFDA tentative nod for anti-asthma tabletsGlenmark said it has received tentative approval from the US health regulator to market its tablets used for treating asthma and seasonal a...
Load More
